Aptahem AB (publ) (NGM:APTA)
Sweden
· Delayed Price · Currency is SEK 0.678
+0.038 (5.94%)
At close: Apr 28, 2026
Aptahem AB Revenue
In the year 2025, Aptahem AB had annual revenue of 2.59M SEK, down -32.73%. Aptahem AB had revenue of 829.09K in the quarter ending December 31, 2025, with 4.98% growth.
Revenue
2.59M
Revenue Growth
-32.73%
P/S Ratio
5.50
Revenue / Employee
861.70K
Employees
3
Market Cap
14.22M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fluicell AB | 15.22M |
| NanoEcho AB | 487.00K |
| Biosergen AB | 2.09M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| 2cureX AB | 1.98M |
| Nanologica AB | 21.13M |
| Pila Pharma AB | 1.13M |
| Alzinova AB | 26.80M |